CH672598A5 - - Google Patents
Download PDFInfo
- Publication number
- CH672598A5 CH672598A5 CH1339/87A CH133987A CH672598A5 CH 672598 A5 CH672598 A5 CH 672598A5 CH 1339/87 A CH1339/87 A CH 1339/87A CH 133987 A CH133987 A CH 133987A CH 672598 A5 CH672598 A5 CH 672598A5
- Authority
- CH
- Switzerland
- Prior art keywords
- film
- composition according
- pharmaceutical composition
- active ingredients
- forming polymers
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 claims description 19
- 239000004480 active ingredient Substances 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 17
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 14
- 239000004202 carbamide Substances 0.000 claims description 14
- 230000002682 anti-psoriatic effect Effects 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 201000004681 Psoriasis Diseases 0.000 claims description 10
- 239000013543 active substance Substances 0.000 claims description 10
- 229960002311 dithranol Drugs 0.000 claims description 10
- 239000006185 dispersion Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000002560 therapeutic procedure Methods 0.000 claims description 8
- 239000008177 pharmaceutical agent Substances 0.000 claims description 7
- 239000003862 glucocorticoid Substances 0.000 claims description 3
- 229940037128 systemic glucocorticoids Drugs 0.000 claims description 3
- 125000000129 anionic group Chemical group 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 238000009826 distribution Methods 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 26
- 210000003491 skin Anatomy 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 239000011888 foil Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004283 Sodium sorbate Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 4
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 4
- 235000019250 sodium sorbate Nutrition 0.000 description 4
- 229920003091 Methocel™ Polymers 0.000 description 3
- YUTJCNNFTOIOGT-UHFFFAOYSA-N anthracene-1,8,9-triol Chemical compound C1=CC(O)=C2C(O)=C3C(O)=CC=CC3=CC2=C1 YUTJCNNFTOIOGT-UHFFFAOYSA-N 0.000 description 3
- 239000007979 citrate buffer Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 2
- POPFMWWJOGLOIF-XWCQMRHXSA-N Flurandrenolide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O POPFMWWJOGLOIF-XWCQMRHXSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- ZZBWSNKBZKPGAK-UHFFFAOYSA-N chrysophanol-9-anthrone Chemical compound C1=CC=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O ZZBWSNKBZKPGAK-UHFFFAOYSA-N 0.000 description 2
- 229960002303 citric acid monohydrate Drugs 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229960004511 fludroxycortide Drugs 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 229920000193 polymethacrylate Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 229920003136 Eudragit® L polymer Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical class C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229950003429 sorbitan palmitate Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863612305 DE3612305A1 (de) | 1986-04-11 | 1986-04-11 | Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH672598A5 true CH672598A5 (en:Method) | 1989-12-15 |
Family
ID=6298514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1339/87A CH672598A5 (en:Method) | 1986-04-11 | 1987-04-07 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4826677A (en:Method) |
| JP (1) | JPS62242614A (en:Method) |
| CH (1) | CH672598A5 (en:Method) |
| DE (1) | DE3612305A1 (en:Method) |
| FR (1) | FR2596991A1 (en:Method) |
| GB (1) | GB2188844B (en:Method) |
| NL (1) | NL8700814A (en:Method) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8729855D0 (en) * | 1987-12-22 | 1988-02-03 | Drythanol Ltd | New dithranol compositions |
| CA2008775C (en) * | 1989-02-24 | 1998-12-22 | Alberto Ferro | Nail lacquer |
| IN172390B (en:Method) * | 1989-07-18 | 1993-07-10 | Ethicon Inc | |
| JPH0794378B2 (ja) * | 1989-08-18 | 1995-10-11 | 久光製薬株式会社 | エアゾール剤 |
| US4996046A (en) * | 1989-11-24 | 1991-02-26 | Warshaw Thelma G | Infrared treatment for psoriasis |
| US5176912A (en) * | 1991-01-29 | 1993-01-05 | Orestes Cabezas | Method of treating psoriasis |
| US5650171A (en) * | 1992-04-29 | 1997-07-22 | Penederm, Inc. | Retinoic acid-containing polyether-polyurethane compositions |
| US5248494A (en) * | 1992-06-10 | 1993-09-28 | Young Pharmaceuticals Inc. | Method of reducing anthralin induced inflammation and staining |
| DE4310012A1 (de) * | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
| NZ267488A (en) * | 1993-07-28 | 1997-09-22 | Pfizer | Topical psoriasis treatment composition comprising a film-forming agent |
| US5800831A (en) * | 1993-07-28 | 1998-09-01 | Pfizer Inc. | Psoriasis treatment with polymer film |
| US6113893A (en) * | 1993-07-28 | 2000-09-05 | Pfizer Inc. | Psoriasis treatment |
| ATE197163T1 (de) * | 1993-08-19 | 2000-11-15 | Univ Yale | Kosmetische melanine |
| US5744125A (en) * | 1993-08-19 | 1998-04-28 | Yale University | Cosmetic melanins |
| US5776920A (en) * | 1995-08-02 | 1998-07-07 | Quarles; Ruth | Method for treatment of psoriasis |
| US5955081A (en) * | 1996-03-22 | 1999-09-21 | Moady Marzook | Antipsoriatic compositions, method of making, and method of using |
| DE19653606A1 (de) * | 1996-12-20 | 1998-06-25 | Roehm Gmbh | Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher |
| RO118174B1 (ro) * | 1997-08-21 | 2003-03-28 | Aventis Pharma Deutschland Gmbh | Lac de unghii şi utilizarea acestuia |
| US5858372A (en) * | 1997-09-12 | 1999-01-12 | Jacob; George | Herbal medication for the treatment of psoriasis |
| CN1297344A (zh) * | 1998-10-19 | 2001-05-30 | 济拉公司 | 在机体组织上原位形成保护性和/或药性膜的方法及组合物 |
| GB9826656D0 (en) * | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
| ES2209812T3 (es) * | 1999-02-05 | 2004-07-01 | Cipla Ltd. | Pulverizaciones topicas que contienen una composicion filmogena. |
| US6962691B1 (en) | 1999-05-20 | 2005-11-08 | U & I Pharmaceuticals Ltd. | Topical spray compositions |
| IT1319210B1 (it) * | 2000-10-13 | 2003-09-26 | Italiano Biochimico Lisapharma | Pellicola per la somministrazione dermica e transdermica di principiattivi. |
| BR0206307A (pt) * | 2001-01-09 | 2004-07-20 | Israel Dvoretzky | Composição terapêutica formadora de pelìcula e sistema de tratamento para a mesma |
| US6942875B2 (en) * | 2001-07-05 | 2005-09-13 | Closure Medical Corporation | Adhesive treatment for skin yeast infections |
| US6746667B2 (en) | 2001-07-05 | 2004-06-08 | Closure Medical Corporation | Adhesive treatment for tinea pedis |
| US6767552B2 (en) | 2001-07-05 | 2004-07-27 | Closure Medical Corporation | Adhesive treatment for oral fungal infection |
| US6585967B2 (en) | 2001-07-05 | 2003-07-01 | Closure Medical Corporation | Adhesive treatment for tinea cruris |
| US6602496B2 (en) | 2001-07-05 | 2003-08-05 | Closure Medical Corporation | Adhesive treatment for tinea corporis |
| JP2004359585A (ja) * | 2003-06-03 | 2004-12-24 | Medorekkusu:Kk | 被膜形成型の副腎皮質ステロイド薬含有外用製剤 |
| AU2005282789A1 (en) * | 2004-09-01 | 2006-03-16 | Trustees Of Boston University | Use of thyroid hormone conversion inhibitors |
| JP2006131544A (ja) * | 2004-11-05 | 2006-05-25 | Medorekkusu:Kk | 皮膚疾患治療用外用剤 |
| BRPI0609126A2 (pt) * | 2005-03-21 | 2010-02-23 | Lifecare Innovations Pvt Ltd | composição vesicular inter e intra multilamelar |
| GB0518769D0 (en) | 2005-09-14 | 2005-10-19 | Medpharm Ltd | Topical formulations |
| WO2008013493A1 (en) | 2006-07-25 | 2008-01-31 | Iss Immune System Stimulation Ab | Topical treatment of warts |
| US20140135372A1 (en) * | 2010-02-02 | 2014-05-15 | Elliott Farber | Compositions and methods of treatment of inflammatory skin conditions using allantoin |
| KR20150038212A (ko) * | 2012-07-23 | 2015-04-08 | 다우 글로벌 테크놀로지스 엘엘씨 | 경질 캡슐 쉘용 필름 조성물 |
| ES2793404T3 (es) * | 2012-10-11 | 2020-11-13 | Anaplasi Pharmaceuticals Llc | Método y composiciones para el tratamiento de la psoriasis |
| US9717741B2 (en) | 2012-10-11 | 2017-08-01 | Anaplasi Pharmaceuticals Llc | Method and compositions for treating psoriasis |
| JP6224203B2 (ja) * | 2016-12-08 | 2017-11-01 | アナプラシ ファーマシューティカルズ エルエルシー | 乾癬を治療するための組成物 |
| JP6491293B2 (ja) * | 2017-10-04 | 2019-03-27 | アナプラシ ファーマシューティカルズ エルエルシー | 乾癬を治療するためのエアロゾル、ムース、又はフォームの組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1034623A (en) * | 1964-02-18 | 1966-06-29 | Johnson & Johnson | Topical corticosteroid compositions and dressings |
| FR2047874A6 (en:Method) * | 1969-06-10 | 1971-03-19 | Nouvel Lucien | |
| US4007271A (en) * | 1971-11-26 | 1977-02-08 | Sterling Drug Inc. | Dermatalogical compounds and compositions |
| GB1467957A (en) * | 1974-05-20 | 1977-03-23 | Hoke Inc | Mounting adaptor |
| GB1504007A (en) * | 1976-06-28 | 1978-03-15 | Dermal Lab Ltd | Compositions containing dithranol |
| US4496588A (en) * | 1977-07-11 | 1985-01-29 | Merrell Toraude Et Compagnie | Method of treating psoriasis |
| JPS557272A (en) * | 1978-06-16 | 1980-01-19 | Rech Pharma Sa | Drug composition containing urea |
| US4210633A (en) * | 1978-10-20 | 1980-07-01 | Eli Lilly And Company | Flurandrenolide film formulation |
| IL65588A (en) * | 1981-07-10 | 1985-04-30 | Orion Yhtymae Oy | Pharmaceutical compositions for the treatment of skin |
| LU83710A1 (fr) * | 1981-10-23 | 1983-06-07 | Cird | Matrice de diffusion polymerique a base d'anthraline ou de l'un de ses derives et son application dans le traitement des maladies de la peau |
| GB2116423B (en) * | 1982-01-13 | 1986-08-28 | Quinoderm Ltd | Dermatological compositions |
| LU84979A1 (fr) * | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
-
1986
- 1986-04-11 DE DE19863612305 patent/DE3612305A1/de not_active Withdrawn
-
1987
- 1987-01-29 FR FR8701057A patent/FR2596991A1/fr not_active Withdrawn
- 1987-04-02 US US07/033,248 patent/US4826677A/en not_active Expired - Fee Related
- 1987-04-07 CH CH1339/87A patent/CH672598A5/de not_active IP Right Cessation
- 1987-04-07 NL NL8700814A patent/NL8700814A/nl not_active Application Discontinuation
- 1987-04-10 JP JP62087264A patent/JPS62242614A/ja active Pending
- 1987-04-10 GB GB8708659A patent/GB2188844B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62242614A (ja) | 1987-10-23 |
| NL8700814A (nl) | 1987-11-02 |
| GB8708659D0 (en) | 1987-05-13 |
| FR2596991A1 (fr) | 1987-10-16 |
| GB2188844A (en) | 1987-10-14 |
| GB2188844B (en) | 1990-11-21 |
| US4826677A (en) | 1989-05-02 |
| DE3612305A1 (de) | 1987-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH672598A5 (en:Method) | ||
| DE3685545T2 (de) | System zur transdermalen abgabe von nitroglycerin. | |
| DE69715049T2 (de) | Tranilast enthaltendes externum und verfahren zu dessen herstellung | |
| DE2012775C3 (de) | Salbenfohe und Verfahren zu ihrer Herstellung | |
| EP0020905B1 (de) | Pharmazeutische Zubereitung in Form eines Polyacrylatfilmes und deren Herstellung | |
| EP0439180B1 (de) | Transdermales therapeutisches System mit dem Wirkstoff Tulobuterol | |
| DE2418345C2 (de) | Pharmazeutisches Mittel für äußerliche Anwendung an menschlicher Haut | |
| DE3111550C2 (de) | Antiphlogistisches analgetisches Pflaster | |
| DE69007886T2 (de) | Östradiol enthaltende Mittel und Verfahren zur topischen Anwendung. | |
| DE69218932T2 (de) | Transdermale therapeutische Formulierung | |
| EP0913154B1 (de) | Antipsoriatisch wirksamer Nagellack | |
| DE2721603C3 (de) | Beschichtete Körnchen aus Alkalimetallsalzen der Polyacrylsäure und Verfahren zu ihrer Herstellung | |
| DE2933250A1 (de) | Abdeckmaterial | |
| DD145062A5 (de) | Transparentes fluessigkeitsverbandsmaterial | |
| DE2725261A1 (de) | Transparentes fluessigkeitsverbandmaterial, seine herstellung und verwendung | |
| DE1617780A1 (de) | Heilmittel mit vernarbender Wirkung | |
| DE69029969T2 (de) | Kunsthaut | |
| DE69010317T2 (de) | Acrylgel und seine Herstellung. | |
| DE69023169T3 (de) | Anwendung von feuchtem Sucralfatgel als Träger für Arzneimittel mit topischen Aktivitäten und für kosmetische Präparate. | |
| DE69019151T2 (de) | Salbe enthaltend Deprodone proprionate. | |
| DE3710216C2 (en:Method) | ||
| DE60214207T2 (de) | Nagellack enthaltend tazaroten und verwendung dessen zur behandlung und/oder zur prävention von psoriasis | |
| DE1804801B2 (de) | Mittel zur aknebehandlung | |
| DD272414A5 (de) | Verfahren zur herstellung eines die wundheilung foerdernden arzneimittelpraeparates | |
| DE3204512A1 (de) | Polypeptid-haltiges folienmaterial fuer kosmetische und pharmazeutische zwecke |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |